ArticlePsychiatry and clinical psychopharmacology2024
Rare Case of Acute Psychotic Disorder Associated with Immunosuppressant Medications Use After Kidney Transplantation.
Article in Psychiatry and clinical psychopharmacology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Renal transplantation is the treatment of choice for patients with end-stage renal failure as it provides patients with the best quality of life because of its survival benefits, either short or long-term. However, despite the benefits of renal transplantation over dialysis, the life-long immunosuppressant treatment needed after kidney transplantation has several drawbacks. The present case developed a psychotic disorder after 8 years of regular intake of immunosuppressant medications tacrolimus and prednisone. He was switched to cyclosporine, and the dose of prednisone was decreased, but he only showed partial improvement in his behavior. The patient was started on the antipsychotic drug risperidone, and the delusions subsided within 12 weeks of starting the medication. This case highlights the importance of clinical awareness of rare but severe psychiatric effects due to immunosuppressant use. In conclusion, early recognition of psychiatric side effects of immunosuppressants and systemic corticosteroids and starting appropriate treatment is essential to prevent more serious psychiatric side effects.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.